2021 Annual Meeting | Epilepsy/Clinical Neurophysiology (EEG) Posters

Date/Time This program spans the entire conference

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) Epilepsy/Clinical Neurophysiology (EEG)

CME Available 0.00 credit

Program Tracks COVID-19

Program Materials Program Evaluations

Event Timeline
07:00 AM - 05:00 PM EDT	Abstract	001 - PROVE Study 506: Analysis of a Retrospective, Phase IV Study of Perampanel in Real-World Clinical Care of Patients Based on Study Site Participation in Previous Clinical Trials Robert T. Wechsler, MD, PhD, F�鶹��ýӳ��
07:00 AM - 05:00 PM EDT	Abstract	002 - Long-term Safety and Efficacy of Add-on Cannabidiol (CBD) for Treatment of Seizures Associated with Tuberous Sclerosis Complex (TSC) in an Open-Label Extension (OLE) Trial (GWPCARE6) James W. Wheless, MD, FAAP, FACP, FAES, FCNS, F�鶹��ýӳ��
07:00 AM - 05:00 PM EDT	Abstract	003 - Long-Term Soticlestat Treatment in Patients with Developmental and/or Epileptic Encephalopathies in the ENDYMION Ongoing Open-Label Extension Study Cecil D. Hahn, MD
07:00 AM - 05:00 PM EDT	Abstract	004 - Efficacy of Add-on Cannabidiol (CBD) Treatment in Patients with Tuberous Sclerosis Complex (TSC) and a History of Infantile Spasms (IS): Post Hoc Analysis of Phase 3 Trial GWPCARE6 James W. Wheless, MD, FAAP, FACP, FAES, FCNS, F�鶹��ýӳ��
07:00 AM - 05:00 PM EDT	Abstract	005 - Dose Adjustments to Concomitant Antiseizure Medications: Post-hoc Analysis of a Phase 3, Open-Label Study of Cenobamate for Treatment of Uncontrolled Focal Seizures William E. Rosenfeld, MD, F�鶹��ýӳ��
07:00 AM - 05:00 PM EDT	Abstract	006 - Consistent and Durable Long-Term Efficacy from Two Open-Label Studies of Cenobamate William E. Rosenfeld, MD, F�鶹��ýӳ��
07:00 AM - 05:00 PM EDT	Abstract	007 - Efficacy and Safety of Low- and High-Dose Perampanel as First Adjunctive Therapy in Patients With Partial-Onset Seizures (POS) With or Without Secondarily Generalized Seizures (SGS): Post Hoc Analysis of the FAME Study Dae W. Seo, MD
07:00 AM - 05:00 PM EDT	Abstract	008 - Perampanel Monotherapy Beyond Initial Titration to Achieve Seizure Freedom in Patients With Partial-Onset Seizures (POS), With/Without Secondarily Generalized Seizures (SGS): Post Hoc Analysis of Phase III Study 342 (FREEDOM) Ryan Edbert Husni
07:00 AM - 05:00 PM EDT	Abstract	009 - Long-Term (1-Year) Evaluation of Adjunctive Perampanel on Mental Health in Pediatric Patients (Aged 4-<12 Years) with Partial-Onset Seizures (POS) or Primary Generalized Tonic-Clonic Seizures (PGTCS) in Study 311 Rohit Shankar
07:00 AM - 05:00 PM EDT	Abstract	010 - Long-Term (1-Year) Seizure Freedom with Adjunctive Perampanel in Pediatric Patients (Aged 4–<12 Years) with Partial-Onset Seizures (POS) or Primary Generalized Tonic-Clonic Seizures (PGTCS): Post Hoc Analysis of Study 311 Robert Flamini, MD
07:00 AM - 05:00 PM EDT	Abstract	011 - Post-hoc Analysis of a Phase 3, Open-Label Study of Cenobamate for Treatment of Uncontrolled Focal Seizures: Effects of Dose Reductions to Concomitant Lamotrigine and Carbamazepine Louis Ferrari
07:00 AM - 05:00 PM EDT	Abstract	012 - Efficacy of Adjunctive Eslicarbazepine Acetate in Patients with Focal Seizures, According to Baseline Seizure Frequency: A Post-Hoc Analysis of Data from a Phase IV Clinical Trial Sami M. Aboumatar, MD
07:00 AM - 05:00 PM EDT	Abstract	013 - Efficacy of Cenobamate by Concomitant Antiseizure Medications in Patients With Uncontrolled Focal Seizures: Post-hoc Analysis of a Phase 3, Multicenter, Open-Label Study Pavel Klein, MD, F�鶹��ýӳ��
07:00 AM - 05:00 PM EDT	Abstract	014 - Efficacy, Safety and Tolerability of Soticlestat (TAK-935/OV935) as an Adjunctive Therapy in Patients with 15q Duplication Syndrome (Dup15q) or Cyclin-Dependent Kinase-Like 5 Deficiency Disorder (CDD) in a Signal-Finding Phase 2 Study (ARCADE) Scott T. Demarest, MD
07:00 AM - 05:00 PM EDT	Abstract	015 - Post-hoc Analysis of the Effects of Dose Reductions of Concomitant Clobazam in a Phase 3, Open-Label Study of Cenobamate for the Treatment of Uncontrolled Focal Seizures Bassel W. Abou-Khalil, MD, F�鶹��ýӳ��
07:00 AM - 05:00 PM EDT	Abstract	016 - Efficacy and Safety of Cannabidiol (CBD) in Patients with Treatment-Resistant Epilepsies (TREs) in the Expanded Access Program (EAP): Additional Efficacy Data for Convulsive and Nonconvulsive Seizure Types Paul Lyons, MD
07:00 AM - 05:00 PM EDT	Abstract	017 - MOMENTUM (Study 304; NCT04572243): A Multicenter, Phase III, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of Adjunctive Lorcaserin in Patients with Dravet Syndrome (DS) Orrin Devinsky, MD, F�鶹��ýӳ��
07:00 AM - 05:00 PM EDT	Abstract	018 - ELEVATE Study 410 Initial Results: Phase IV Study of Perampanel as Monotherapy or First Adjunctive Therapy in Patients Aged =4 Years with Partial-Onset Seizures (POS) or Primary Generalized Tonic-Clonic Seizures (PGTCS) Vineet Punia, MD
07:00 AM - 05:00 PM EDT	Abstract	019 - Efficacy and Safety of Adjunctive Perampanel for Myoclonic and Absence Seizures: Post Hoc Pooled Analysis of Adult, Adolescent, and Pediatric Patients in Studies 332, 311, and 232 Christian Brandt, MD
07:00 AM - 05:00 PM EDT	Abstract	020 - Perampanel Monotherapy for the Treatment of Epilepsy: Evidence From a Clinical Trial (Study 342) and Real-World Use (Studies 504 and 506) Antonio Gil-Nagel, MD
07:00 AM - 05:00 PM EDT	Abstract	021 - Effectiveness and Tolerability of Perampanel in Epilepsy Patients Treated in Routine Clinical Practice: a Global Pooled Analysis Study Wendyl J. D'Souza, MD, MBChB
07:00 AM - 05:00 PM EDT	Abstract	022 - Seizure Reduction With Adjunctive Cenobamate During Titration in the Phase 3 C021 Study Victor Biton, MD
07:00 AM - 05:00 PM EDT	Abstract	023 - Adjunctive Cenobamate Dose in Seizure-Free Patients by Baseline Seizures in the Phase 3 C021 Study Sami M. Aboumatar, MD
07:00 AM - 05:00 PM EDT	Abstract	024 - Long-Term Efficacy of Cenobamate by Concomitant Antiseizure Medication: Post-hoc Analysis of the C017 Open-label Extension Study Louis Ferrari
07:00 AM - 05:00 PM EDT	Abstract	025 - Long-term Efficacy and Safety of Cannabidiol (CBD) in Patients with Tuberous Sclerosis Complex (TSC): 4-year Results from the Expanded Access Program (EAP) Leon A. Weinstock, MD
07:00 AM - 05:00 PM EDT	Abstract	026 - Lipid profile with eslicarbazepine acetate and carbamazepine monotherapy in adult patients with newly diagnosed focal-onset seizures: Post-hoc analysis from a phase III, randomized, double-blind study and a 2-year open-label extension ESL study Eugen Trinka
07:00 AM - 05:00 PM EDT	Abstract	027 - Diagnostic Yield of Electroencephalography When Seizure is Suspected in Acute Ischemic Stroke Prathana Hareesh, MBBS, MPH
07:00 AM - 05:00 PM EDT	Abstract	028 - LRDA and LPDs EEG patterns association with seizures in critically ill patients: a systematic review Faisal A. Ibrahim, MD
07:00 AM - 05:00 PM EDT	Abstract	029 - Events Recording in Patients who Underwent Ambulatory EEG and Inpatient EEG Monitoring Yara Mikhaeil-Demo, MD
07:00 AM - 05:00 PM EDT	Abstract	030 - Continuous EEG Monitoring in Aneurysmal Subarachnoid Hemorrhage: Clinical Outcomes and Costs Jafar Hashem, MD
07:00 AM - 05:00 PM EDT	Abstract	031 - EEG Reactivity and Evoked Response Testing Predict Positive Outcomes Following Cardiac Arrest Bryan D. Clements II, DO
07:00 AM - 05:00 PM EDT	Abstract	032 - Use of Continuous Electroencephalogram (cEEG) in Critically Ill Patients Ahyuda Oh, PhD
07:00 AM - 05:00 PM EDT	Abstract	033 - How Much Time is Enough? Establishing an Optimal Duration of Recording for Ambulatory Video EEG Hans Klein, PhD
07:00 AM - 05:00 PM EDT	Abstract	034 - Clinical characteristics Associated With Delayed Seizure Detection Among Critically Ill Patients undergoing Continuous EEG(cEEG) Monitoring Ifrah Zawar, MD
07:00 AM - 05:00 PM EDT	Abstract	035 - Quantitative EEG Markers of Hypoglycemia Sergiu I. Abramovici, MD
07:00 AM - 05:00 PM EDT	Abstract	036 - Extreme Delta Brush: The Key to Anti-NMDA Receptor Encephalitis Courtney Filliben
07:00 AM - 05:00 PM EDT	Abstract	037 - Unique EEG findings in Hashimoto Encephalitis – Migrating lateralized periodic discharges – case report Sushma R. Yerram, MD
07:00 AM - 05:00 PM EDT	Abstract	038 - Improving Ictal Testing in the Epilepsy Monitoring Unit via Assessment Standardization (Long-term Follow Up) Brian J. Hanrahan, MD
07:00 AM - 05:00 PM EDT	Abstract	039 - Concordance Between Patient-Reported And Physician-Reported Seizure Semiology Andrew Lin, MD
07:00 AM - 05:00 PM EDT	Abstract	040 - Characterizing the Driving Dilemma among Patients with Nonepileptic Events: A Single-Center Prospective Cohort Study Sara Dawit, MD
07:00 AM - 05:00 PM EDT	Abstract	041 - Psychogenic non-epileptic seizures with comorbid epilepsy: insights from patient and caregiver characteristics Aida Risman, MD
07:00 AM - 05:00 PM EDT	Abstract	042 - A Descriptive Study of Eye Movements in Versive Seizures Neel Fotedar, MD
07:00 AM - 05:00 PM EDT	Abstract	043 - Dissociative seizures across the adult lifespan: female sex, delay to diagnosis and disability Wesley Kerr, MD, PhD
07:00 AM - 05:00 PM EDT	Abstract	044 - The Role of Semantic Saliency in Reading Epilepsy: A Case Report Wentao Li, MD
07:00 AM - 05:00 PM EDT	Abstract	045 - Two Cases of Scalp EEG Negative, Stereotactic EEG Proven Insular Epilepsy with Interesting Semiologies Denise Li, MD
07:00 AM - 05:00 PM EDT	Abstract	046 - Excessive Yawning as an Ictal Manifestation of Post-stroke Seizures Anna McDonnell
07:00 AM - 05:00 PM EDT	Abstract	047 - Postictal Psychosis and Postictal Delirium: A Report of Five Cases
07:00 AM - 05:00 PM EDT	Abstract	048 - Quantitative EEG during alteration of consciousness in psychogenic non-epileptic seizures Katherine Werbaneth, MD
07:00 AM - 05:00 PM EDT	Abstract	049 - Depression and Anxiety Precede the Onset of Spells in Patients with Psychogenic Nonepileptic Seizures Omar N. Nofal, MD
07:00 AM - 05:00 PM EDT	Abstract	050 - Characterization of Electroencephalographic Abnormalities and Their Radiographic Correlates Associated with COVID-19 Ahmad A. Ballout, MD
07:00 AM - 05:00 PM EDT	Abstract	051 - Changes in Health-Seeking Behavior Among Adult and Pediatric Patients with Seizures during the COVID-19 Pandemic William C. Leung, MBBS, MRCP, FHKAM
07:00 AM - 05:00 PM EDT	Abstract	052 - Electroencephalographic findings in hospitalized patients with SARS-COV-2 (COVID-19) encephalopathy Niyatee Samudra, MD
07:00 AM - 05:00 PM EDT	Abstract	053 - Electroencephalographic findings in COVID-19 patients: A systematic review Katrina Roberto, MD
07:00 AM - 05:00 PM EDT	Abstract	054 - Status epilepticus and other epileptiform EEG findings in patients with COVID-19 Katherine Werbaneth, MD
07:00 AM - 05:00 PM EDT	Abstract	055 - EEG Findings in COVID-19 Positive Patients: A Case Series Uma Menon, MD, MBA, F�鶹��ýӳ��
07:00 AM - 05:00 PM EDT	Abstract	056 - Ceribell EEG Shortens Seizure Diagnosis and Workforce Time and Is Useful for COVID Isolation Marian P. LaMonte, MD, MSN, F�鶹��ýӳ��
07:00 AM - 05:00 PM EDT	Abstract	057 - The Efficacy, Safety and Outcomes of Responsive neurostimulation (RNS) therapy in Older Adults Ifrah Zawar, MD
07:00 AM - 05:00 PM EDT	Abstract	058 - Antiepileptic Drugs Use after Deep Brain Stimulation Therapy Haley Phillips, MD
07:00 AM - 05:00 PM EDT	Abstract	059 - Vagus Nerve Stimulation AutoStim Feature, A Three-Year Study Prashant K. Rai, MD
07:00 AM - 05:00 PM EDT	Abstract	060 - A Case of Super-Refractory Epilepsia Partialis Continua Successfully Treated with Repetitive Transcranial Magnetic Stimulation Busranur Agac, MD
07:00 AM - 05:00 PM EDT	Abstract	061 - VNS Used In The Elderly Population Ana Suller Marti, MD
07:00 AM - 05:00 PM EDT	Abstract	062 - Brain Responsive Stimulation for Treatment of Refractory Frontal Lobe Epilepsy Carolyn Tsai, MD
07:00 AM - 05:00 PM EDT	Abstract	063 - Crescendo in EKG Heterogeneity Is Superior to Heart Rate Elevation as a Warning Sign of Impending Generalized Tonic-Clonic Seizures Trudy Pang, MD
07:00 AM - 05:00 PM EDT	Abstract	064 - Analysis of Brief Potentially Ictal Rhythmic Discharges (BIRDs) and seizures in Epilepsy Patients with Responsive Neurostimulation undergoing Scalp Electroencephalography Hernan Nicolas Lemus Esquivel, MD
07:00 AM - 05:00 PM EDT	Abstract	065 - Integrated Digital System for Long-term Behavioral Tracking and Adaptive Electrical Brain Stimulation: Canines and Humans with Epilepsy Vaclav Kremen
07:00 AM - 05:00 PM EDT	Abstract	066 - Preclinical Development of Human Inhibitory Interneuron Cell Therapy (NTX-001) for Chronic Focal Epilepsy Mansi B. Parekh, PhD
07:00 AM - 05:00 PM EDT	Abstract	067 - Relationship Between Genetic Variants and Disease Characteristics in Patients with SCN8A Developmental and Epileptic Encephalopathy (SCN8A-DEE) or SCN8A-Related Epilepsy Dietrich Haubenberger, MD, F�鶹��ýӳ��
07:00 AM - 05:00 PM EDT	Abstract	069 - Evaluating the Epidemiological Burden of KCNQ2 Epilepsy Celene Grayson, PhD
07:00 AM - 05:00 PM EDT	Abstract	070 - Electroclinical Features in MECP2 Duplication Syndrome: Pediatric case series Jocelyn B. Lorenzo, MD
07:00 AM - 05:00 PM EDT	Abstract	071 - Utility of Genetic Testing in Epilepsy Surgery Decision Making Irina Podkorytova
07:00 AM - 05:00 PM EDT	Abstract	072 - Alternating Seizure Focus In Mitochondrial Disease Yazan Nofal, MD
07:00 AM - 05:00 PM EDT	Abstract	073 - Genetic Variation Associated with Post-operative Seizure Freedom in Temporal Lobe Epilepsy Shreya Louis, MD, MS
07:00 AM - 05:00 PM EDT	Abstract	074 - Caregivers’ Perspectives on the Long-term Seizure- and Non-seizure-related Benefits of Fenfluramine on Patients with Dravet Syndrome and their Families Dagmar Amtmann
07:00 AM - 05:00 PM EDT	Abstract	075 - Long-Term Anti-Seizure Medication Continuation after Acute Strokes Pradeep Chandan, DO
07:00 AM - 05:00 PM EDT	Abstract	076 - Differences in rates of elective video-EEG monitoring admission by race/ethnicity and insurance status in New Jersey Brad K. Kamitaki, MD
07:00 AM - 05:00 PM EDT	Abstract	077 - Evaluation of Epilepsy Patients to Ascertain Risk Factors for 30-day Hospital Readmission Aakriti Kothiwal
07:00 AM - 05:00 PM EDT	Abstract	078 - Women with Epilepsy and Postpartum Toxicity: A Retrospective Analysis Leslie Siegel, PharmD
07:00 AM - 05:00 PM EDT	Abstract	079 - Postraumatic epilepsy in patients with traumatic brain injury and computed tomography lesions
07:00 AM - 05:00 PM EDT	Abstract	080 - Generalized epilepsy in the elderly undergoing epilepsy monitoring unit evaluation. Majed Alzahrany, MBBS
07:00 AM - 05:00 PM EDT	Abstract	081 - The effect of weight reduction surgery on antiseizure drug levels and seizure frequency. James D. Triplett, MBBS
07:00 AM - 05:00 PM EDT	Abstract	082 - Evaluation of medication adherence in an inter-professional epilepsy clinic Caroline Kim, Pharmacist
07:00 AM - 05:00 PM EDT	Abstract	083 - Pre-Surgical Evaluation and Management of Drug-Resistant Post-Stroke Epilepsy Miguel Arevalo Astrada
07:00 AM - 05:00 PM EDT	Abstract	084 - Treatment gaps and challenges in epilepsy care in the Philippines
07:00 AM - 05:00 PM EDT	Abstract	085 - Post-traumatic Epilepsy (PTE): Clinical, Radiographic and Electroencephalographic Features and Outcome Hira Pervez, MD, MBBS
07:00 AM - 05:00 PM EDT	Abstract	086 - Role of Anti-Seizure Drugs in the Treatment of Post-Stroke Seizures; Results Analysis from Retrospective Epilepsy Database Sidra Saleem, MD
07:00 AM - 05:00 PM EDT	Abstract	087 - How #Epilepsy is Viewed on Social Media Steven Gangloff, MD
07:00 AM - 05:00 PM EDT	Abstract	088 - Coping And Resilience In Epilepsy : A Descriptive Study
07:00 AM - 05:00 PM EDT	Abstract	089 - Reducing Emergency Room Visits for Patients with Epilepsy: A Quality Improvement Project Ramsha A. Bhutta, MD
07:00 AM - 05:00 PM EDT	Abstract	090 - Seizures After Liver Transplant Franco E. Appiani, MD
07:00 AM - 05:00 PM EDT	Abstract	091 - Seizures and Kidney Transplantation: description of a 10-year cohort
07:00 AM - 05:00 PM EDT	Abstract	092 - Bupropion Overdose Induced Reversible Burst Suppression and Myoclonic Seizures Monica J. Goodman
07:00 AM - 05:00 PM EDT	Abstract	093 - Factors influencing on quality of life in patients with epilepsy
07:00 AM - 05:00 PM EDT	Abstract	094 - Evaluation of Epilepsy Sub-Classification and Optimal Treatment Plan in Post-Stroke Epilepsy: A Single Center Experience Lilly Fagatele
07:00 AM - 05:00 PM EDT	Abstract	095 - Natural Progesterone Reduces Seizures in Women with Epilepsy with Strong Catamenial Tendency: A Pilot Study Alise K. Carlson, MD
07:00 AM - 05:00 PM EDT	Abstract	096 - Treatment of Adult Onset Rasmussen's Encephalitis with Tocilizumab Sotiris G. Mitropanopoulos, MD
07:00 AM - 05:00 PM EDT	Abstract	097 - Racial Differences in Mortality from Status Epilepticus Ali A. Fadhil, MD
07:00 AM - 05:00 PM EDT	Abstract	098 - Time to Loading Conventional Anti-seizure Medications in Patients with Status Epilepticus: A Quality Improvement Project Arooj Kohli, MD
07:00 AM - 05:00 PM EDT	Abstract	099 - Low Pyridoxine levels are associated with Status Epilepticus Clio A. Rubinos, MD, MSCR
07:00 AM - 05:00 PM EDT	Abstract	100 - Posterior Reversible Encephalopathy Syndrome Presenting with Epilepsia Partialis Continua induced by Pseudo-hyperaldosteronism Secondary to Chronic Ingestion of Licorice Faddi G. Saleh Velez, MD
07:00 AM - 05:00 PM EDT	Abstract	101 - Subacute encephalopathy with seizures in alcoholics (SESA) syndrome – a subtype of non-convulsive status epilepticus (NCSE). Aissata Diawara, MD
07:00 AM - 05:00 PM EDT	Abstract	102 - Characterization of Memory Outcome Following Temporal Lobe Resection in Children with Epilepsy Navkiranjot Kaur
07:00 AM - 05:00 PM EDT	Abstract	103 - Perampanel Blocks Refractory Status Epilepticus and its Consequences. Claude G. Wasterlain, MD, F�鶹��ýӳ��
07:00 AM - 05:00 PM EDT	Abstract	104 - Patient Preference of Anterior Temporal Lobe Lobectomy versus Laser Interstitial Thermal Therapy Aissata Diawara, MD
07:00 AM - 05:00 PM EDT	Abstract	105 - Changes in fractional amplitude of low frequency fluctuations (fALFF) changes after epilepsy surgery in patients with temporal lobe epilepsy Niyatee Samudra, MD
07:00 AM - 05:00 PM EDT	Abstract	106 - Levetiracetam and Lacosamide in the treatment of Non-Convulsive Status Epilepticus Asia Payne, MD
07:00 AM - 05:00 PM EDT	Abstract	107 - Comparison of EEG and Neuroimaging Modalities in Localizing Epileptogenic Foci in Pediatric Epilepsy Surgery Min Ye Shen, MD
07:00 AM - 05:00 PM EDT	Abstract	108 - The Impact of Surgical Treatment on the Driving Status of Adults with Refractory Epilepsy Amanda Bingaman
07:00 AM - 05:00 PM EDT	Abstract	109 - Health State Utility Values in Paediatric Subjects with Partial Onset Seizures (POS) or Primary Generalized Tonic Clonic Seizures (PGTCS) receiving Adjunctive Perampanel Andrew Trigg
07:00 AM - 05:00 PM EDT	Abstract	110 - Safety and Tolerability of Intravenous Brivaracetam in Patients with Epilepsy on Concomitant Levetiracetam Treatment Melinda S. Martin, PhD
07:00 AM - 05:00 PM EDT	Abstract	111 - Perampanel Monotherapy in Epilepsy Patients with Focal and Generalized Seizures: Real-World Experience Taoufik Alsaadi, MD, F�鶹��ýӳ��
07:00 AM - 05:00 PM EDT	Abstract	112 - Anti-Seizure Drug Rescue of Voltage Gated Sodium Channel Trafficking Deficient Mutants Jamie A. Simpson
07:00 AM - 05:00 PM EDT	Abstract	113 - Investigation of the differential impact of cannabinoid compounds on seizure frequency and quality of life in patients with epilepsy Danielle S. McDermott, MD
07:00 AM - 05:00 PM EDT	Abstract	114 - Transition from Intravenous to Enteral Administration of Levetiracetam and Lacosamide in the Hospital Setting: Preliminary Data Yong-Bum Song, PharmD
07:00 AM - 05:00 PM EDT	Abstract	115 - A Paradoxical Phenomenon: Seizure Exacerbation following Administration of Anti-seizure Drugs Maria Jaramillo, MD
07:00 AM - 05:00 PM EDT	Abstract	116 - Clinical Update For Cenobamate: Patients’ Experiences of Efficacy and Side Effects Julia Bodnya, MD
07:00 AM - 05:00 PM EDT	Abstract	117 - Perampanel as Early Add-on Therapy for Epilepsy Patients with Focal and Generalized Seizures Treated in Clinical Practice Estevo Santamarina
07:00 AM - 05:00 PM EDT	Abstract	118 - Ten years of post-marketing surveillance data of Eslicarbazepine acetate: reinforcement of the adult safety profile evidenced in clinical trials Helena Gama
07:00 AM - 05:00 PM EDT	Abstract	119 - The effect of epilepsy on sleep quality during pregnancy and postpartum Sheela Toprani, MD, PhD
07:00 AM - 05:00 PM EDT	Abstract	120 - Bone density screening in epilepsy patients Jose A. Montes-Rivera, MD, F�鶹��ýӳ��
07:00 AM - 05:00 PM EDT	Abstract	121 - The utility of the GAD-7 anxiety, NDDI-E depression, Epworth sleepiness and QOLIE-31-P quality of life scales in patients with epilepsy in real clinical practice Alicia Gonzalez-Martinez, MD
07:00 AM - 05:00 PM EDT	Abstract	122 - The Co-occurrence of Dementia in those with Epilepsy is Associated with 30-day Readmission - A Population-based Study Helaina Lehrer, MD
07:00 AM - 05:00 PM EDT	Abstract	123 - Sleep central apnea does not correlate with peri-ictal breathing dysfunction Yao Cheng, MBBS
07:00 AM - 05:00 PM EDT	Abstract	124 - The Effects of Psychiatric Co-Morbidity on Recurrent Emergency Department (ED) Visits in Patients with Epileptic Seizures – Experience from a Single County Hospital Anika Morgado
07:00 AM - 05:00 PM EDT	Abstract	125 - Factors that Affect the Employability of Patients with Epilepsy in Hawaii: A Look at Race, Comorbidities, and Marital Status. Rachel Gorenflo
07:00 AM - 05:00 PM EDT	Abstract	126 - Subjective Memory Complaints and Memory Dysfunction in Epilepsy Kristin Bumsch
07:00 AM - 05:00 PM EDT	Abstract	127 - Evaluation of Diazepam Nasal Spray in Patients with Epilepsy Concomitantly Using Maintenance Benzodiazepines: Interim Analysis from a Phase 3, Long-term, Open-label Safety Study Eric Segal, MD
07:00 AM - 05:00 PM EDT	Abstract	128 - Treatment Satisfaction, Anxiety Level, and Confidence About Traveling With Midazolam Nasal Spray in Patients With Seizure Clusters: Phase III, Open-Label Extension Trial Toufic Fakhoury, MD
07:00 AM - 05:00 PM EDT	Abstract	129 - Time to Second Doses in Emergency Seizure Patients Treated With Valtoco® (diazepam nasal spray) Across 24 Hours: Subgroup Results From a Completed Phase 3, Open-label, Repeat Dose Safety Study James W. Wheless, MD, FAAP, FACP, FAES, FCNS, F�鶹��ýӳ��
07:00 AM - 05:00 PM EDT	Abstract	130 - Examining the Patient Experience With Diazepam Nasal Spray for Seizure Clusters: Patient-reported Results From an Exit Survey of a Phase 3, Open-label, Repeat Dose Safety Study Patricia E. Penovich, MD, F�鶹��ýӳ��
07:00 AM - 05:00 PM EDT	Abstract	131 - Return to Full Baseline Functionality After Repeated Intermittent Use of Midazolam Nasal Spray in Patients With Seizure Clusters: Post-Hoc Analysis of an Open-Label Extension Trial Kamil Detyniecki, MD
07:00 AM - 05:00 PM EDT	Abstract	132 - Exploring the Impact of Need for a Second Dose of Rescue Therapy for Seizure Episodes on Healthcare Utilization
07:00 AM - 05:00 PM EDT	Abstract	133 - Safety Profile of Valtoco® (diazepam nasal spray) in Patients With Epilepsy: Final Results From a Phase 3, Open-Label, 12-Month Repeat Dose Safety Study James W. Wheless, MD, FAAP, FACP, FAES, FCNS, F�鶹��ýӳ��
07:00 AM - 05:00 PM EDT	Abstract	134 - Intravenous Antiseizure Medication Utilization Patterns Among Seizure Patients Treated in US Hospitals: a Database Analysis Prashant Dongre, MD, MBBS
07:00 AM - 05:00 PM EDT	Abstract	135 - Outcomes of Intravenous Use of Brivaracetam and Levetiracetam for the Treatment of Seizures in US Hospitals Prashant Dongre, MD, MBBS
07:00 AM - 05:00 PM EDT	Abstract	136 - Focused ultrasound ablation of the anterior thalamus for epilepsy Vibhor Krishna
07:00 AM - 05:00 PM EDT	Abstract	137 - Imaging findings and prognostic implications of hippocampal sclerosis subtypes. Shreya Louis, MD, MS
07:00 AM - 05:00 PM EDT	Abstract	138 - Hippocampal Atrophy and Quantitative EEG Markers in Mild Cognitive Impairment in Temporal Lobe Epilepsy versus Extra-Temporal Lobe Epilepsy Mohammed A. ElSherif, MD, PhD, F�鶹��ýӳ��
07:00 AM - 05:00 PM EDT	Abstract	139 - Kratom-Induced Seizures Associated With Reversible Basal Ganglia T1 Hyperintensities on MRI Erik Valenti, MD
07:00 AM - 05:00 PM EDT	Abstract	140 - The stronger the better - diagnostic utility of 7 Tesla MRI in epilepsy patients Mayur Chalia, MD
07:00 AM - 05:00 PM EDT	Abstract	141 - Functional Connectivity and Neurophysiological Evaluation of Patients with Hepatic Cirrhosis Natália d. Fim Nakao, MD
07:00 AM - 05:00 PM EDT	Abstract	142 - Pediatric Phencyclidine (PCP) Intoxication: First Reported Human MRI and EEG Findings Rebecca Stainman, MD

Faculty Disclosures
David Cantu, PhD	Dr. Cantu has received personal compensation for serving as an employee of Sunovion Pharmaceuticals Inc..
Laurie E. Seltzer, DO	Dr. Seltzer has nothing to disclose.
Shaun Hussain, MD	Dr. Hussain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MGC Pharma. Dr. Hussain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zogenix. Dr. Hussain has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Grenwich Biosciences.
Hina N. Dave, MD	Dr. Dave has nothing to disclose.
Lilly Fagatele	Ms. fagatele has nothing to disclose.
	No disclosure on file
Lily Wong-Kisiel, MD, F�鶹��ýӳ��	Dr. Wong-Kisiel has nothing to disclose.
Samden Lhatoo, MD	Dr. Lhatoo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LivaNova. The institution of Dr. Lhatoo has received research support from NIH. Dr. Lhatoo has received intellectual property interests from a discovery or technology relating to health care. Dr. Lhatoo has received publishing royalties from a publication relating to health care.
David C. Diosy, MD	Dr. Diosy has nothing to disclose.
Courtney Filliben	Ms. Filliben has nothing to disclose.
Kore K. Liow, MD, FACP	The institution of Dr. Liow has received research support from UCB. The institution of Dr. Liow has received research support from Livanova. The institution of Dr. Liow has received research support from Biogen. The institution of Dr. Liow has received research support from Novartis. The institution of Dr. Liow has received research support from Eisai. The institution of Dr. Liow has received research support from Engage Therapeutics. The institution of Dr. Liow has received research support from SK Lifescience. The institution of Dr. Liow has received research support from Cerevel. The institution of Dr. Liow has received research support from Xenon. The institution of Dr. Liow has received research support from NeuroDerm. The institution of Dr. Liow has received research support from Avanir. The institution of Dr. Liow has received research support from Annovis. The institution of Dr. Liow has received research support from Acadia. The institution of Dr. Liow has received research support from Prothena. The institution of Dr. Liow has received research support from SAGE. The institution of Dr. Liow has received research support from Annovis. The institution of Dr. Liow has received research support from Cyclerion.
James W. Wheless, MD, FAAP, FACP, FAES, FCNS, F�鶹��ýӳ��	Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Azurity. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for LivaNova. Dr. Wheless has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelius.
Parul Agarwal	Parul Agarwal has nothing to disclose.
Victor Biton, MD	Dr. Biton has nothing to disclose.
Leslie Siegel, PharmD	Ms. Siegel has nothing to disclose.
Jason Viereck, MD, PhD	Dr. Viereck has nothing to disclose.
Todd Grinnell, PhD	Todd Grinnell, PhD has received personal compensation for serving as an employee of Sunovion Pharmaceuticals Inc..
Sang Kun Lee, MD	Prof. Lee has nothing to disclose.
Kristin Bumsch	Kristin Bumsch has nothing to disclose.
Soha Sadeghikhah, MD	Dr. Sadeghikhah has nothing to disclose.
Sergiu I. Abramovici, MD	Dr. Abramovici has nothing to disclose.
Ernesto Aycardi, MD	Dr. Aycardi has received personal compensation for serving as an employee of XENON. Dr. Aycardi has received stock or an ownership interest from XENON.
Analia Calle	Analia Calle has nothing to disclose.
Amir M. Arain, MD, F�鶹��ýӳ��	Dr. Arain has nothing to disclose.
Carlos Santiago Claverie, MD	No disclosure on file
Alejandro Thomson, MD	Dr. Thomson has nothing to disclose.
Sushma R. Yerram, MD	Dr. Yerram has nothing to disclose.
Alexandra Urban, MD, F�鶹��ýӳ��	Dr. Urban has received personal compensation in the range of $0-$499 for serving as a Consultant for Neuropace. Dr. Urban has received personal compensation in the range of $0-$499 for serving as a Consultant for LivaNova.
Stella L. Ngo, PhD	Dr. Ngo has received personal compensation for serving as an employee of Neurelis Inc.. Dr. Ngo has received personal compensation for serving as an employee of Neurelis Inc..
Michael Chez, MD, F�鶹��ýӳ��	Dr. Chez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ucb. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for marinus. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Catalyst. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelsi. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Pharma. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ucb. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst.
Dae W. Seo, MD	Dr. Seo has nothing to disclose.
Prathana Hareesh, MBBS, MPH	Dr. Hareesh has nothing to disclose.
Jody Westbrook	Jody Westbrook has received personal compensation for serving as an employee of Invitae. Jody Westbrook has received stock or an ownership interest from Invitae.
Katie L. Bullinger, MD, PhD	The institution of Dr. Bullinger has received research support from CDC. The institution of Dr. Bullinger has received research support from NIH. The institution of Dr. Bullinger has received research support from Neuropace. Dr. Bullinger has received publishing royalties from a publication relating to health care.
Jerzy P. Szaflarski, MD, PhD, F�鶹��ýӳ��	Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova Inc. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Gidley, Sarli & Marusak, LLP. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Firm. Dr. Szaflarski has stock in AdCel Biopharma, LLC. Dr. Szaflarski has stock in iFovea.
Farhad Sahebkar-Moghaddam, MD	Dr. Sahebkar-Moghaddam has received personal compensation for serving as an employee of Jazz pharmaceuticals. Dr. Sahebkar-Moghaddam has stock in Jazz pharmaceuticals.
Sheela Toprani, MD, PhD	Dr. Toprani has nothing to disclose.
Takafumi Kubota, MD	Dr. Kubota has nothing to disclose.
Orrin Devinsky, MD, F�鶹��ýӳ��	Dr. Devinsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Devinsky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for California Cannabis Enterprises. Dr. Devinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Engage. Dr. Devinsky has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Privateer Holdings. Dr. Devinsky has received personal compensation in the range of $1,000,000+ for serving on a Scientific Advisory or Data Safety Monitoring board for Receptor Holdings. Dr. Devinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rettco. Dr. Devinsky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Silver Spike. Dr. Devinsky has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tevard. Dr. Devinsky has received personal compensation in the range of $1,000,000+ for serving on a Scientific Advisory or Data Safety Monitoring board for Tilray. Dr. Devinsky has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Engage. Dr. Devinsky has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Tevard Biosciences. Dr. Devinsky has stock in Engage. Dr. Devinsky has stock in Empatica. Dr. Devinsky has stock in California Cannabis Enterprises. Dr. Devinsky has stock in Empatica. Dr. Devinsky has stock in Silver Spike. Dr. Devinsky has stock in Docklight Brands. Dr. Devinsky has stock in Egg Rock/Papa Barkley. Dr. Devinsky has stock in Leafly. Dr. Devinsky has stock in Left Coast Ventures. Dr. Devinsky has stock in Privateer Holdings. Dr. Devinsky has stock in Receptor Holdings. Dr. Devinsky has stock in Qstate. The institution of Dr. Devinsky has received research support from GW Pharma. The institution of Dr. Devinsky has received research support from Zogenix. The institution of Dr. Devinsky has received research support from PTC Pharma. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from DOD. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from Epilepsy Foundation. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from NSF. Dr. Devinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Devinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Devinsky has received publishing royalties from a publication relating to health care.
Christa O'hana S. Nobleza, MD	Dr. Nobleza has nothing to disclose.
Lisa Ellison	No disclosure on file
Ajaz Sheikh, MD	Dr. Sheikh has nothing to disclose.
Júlia Espinosa	Júlia Espinosa has nothing to disclose.
Yong-Bum Song, PharmD	Dr. Song has nothing to disclose.
R E. Faught, Jr., MD, F�鶹��ýӳ��	Dr. Faught has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Life Science. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Gideon, Essary, Tardio and Carter PLC, Nashville TN TN law firm. Dr. Faught has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Friedman Dazio and Zulanas Law Firm Birmingham AL. The institution of Dr. Faught has received research support from UCB Pharma. The institution of Dr. Faught has received research support from Cognizance.
Ka-Ho Wong	The institution of Mr. Wong has received research support from The Sumaira Foundation . The institution of Mr. Wong has received research support from The Siegel Rare Neuroimmune Association.
Carolina B. Maciel, MD, MSCR, F�鶹��ýӳ��	Dr. Maciel has received research support from American Heart Association. Dr. Maciel has received research support from National Institute of Health.
Faisal A. Ibrahim, MD	Dr. Ibrahim has nothing to disclose.
Arnold Gammaitoni, PharmD	Dr. Gammaitoni has received personal compensation for serving as an employee of Zogenix Inc.. Dr. Gammaitoni has received stock or an ownership interest from Zogenix Inc..
William L. Bell, MD, F�鶹��ýӳ��	Dr. Bell has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Yerridlaw. The institution of Dr. Bell has received research support from Sk Lifescience.
Tirisham Gyang, MD	Dr. Gyang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono.
Masako Matsunaga	Masako Matsunaga has nothing to disclose.
Constanza Luzon	Constanza Luzon has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. Constanza Luzon has stock in Xenon Pharmaceuticals.
Neel Fotedar, MD	Dr. Fotedar has received research support from NINDS.
Courtney Wusthoff, MD, F�鶹��ýӳ��	Dr. Wusthoff has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for ICON. Dr. Wusthoff has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Wusthoff has received research support from NIH. Dr. Wusthoff has received publishing royalties from a publication relating to health care.
Larisa Reyderman	Larisa Reyderman has nothing to disclose.
Marcia E. Morita-Sherman, MD	An immediate family member of Dr. Morita-Sherman has received personal compensation for serving as an employee of Forrester Research. Dr. Morita-Sherman has received personal compensation for serving as an employee of Eisai Inc.. An immediate family member of Dr. Morita-Sherman has stock in Forrester Research. The institution of Dr. Morita-Sherman has received research support from Cleveland Clinic.
Erik Valenti, MD	Dr. Valenti has received personal compensation in the range of $0-$499 for serving as a Consultant for LVIS.
Dimitrios Arkilo, MD	Dr. Arkilo has received personal compensation for serving as an employee of Sage Therapeutics. Dr. Arkilo has received personal compensation for serving as an employee of Acadia Pharmaceuticals. Dr. Arkilo has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Dr. Arkilo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EcoR1. An immediate family member of Dr. Arkilo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. An immediate family member of Dr. Arkilo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medtronic. Dr. Arkilo has stock in Takeda Pharmaceuticals. Dr. Arkilo has stock in Acadia Pharmaceuticals. Dr. Arkilo has stock in Sage Therapeutics.
Estevo Santamarina	The institution of Estevo Santamarina has received research support from INSTITUTO CARLOS III - GOVERNMENT ENTITY IN SPAIN.
Hai Chen, MD, PhD	Dr. Chen has nothing to disclose.
Mahnaz Asgharnejad, PharmD	Mahnaz Asgharnejad, PharmD has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Mahnaz Asgharnejad, PharmD has stock in GlaxoSmithKline. Mahnaz Asgharnejad, PharmD has stock in Takeda Pharmaceuticals.
Dario J. Englot	No disclosure on file
Mustafa Al-Chalabi, DO	Dr. Al-Chalabi has nothing to disclose.
Nancy R. Foldvary-Schaefer, DO, F�鶹��ýӳ��	Dr. Foldvary-Schaefer has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz. The institution of Dr. Foldvary-Schaefer has received research support from Jazz. The institution of Dr. Foldvary-Schaefer has received research support from Suven. The institution of Dr. Foldvary-Schaefer has received research support from Takeda. Dr. Foldvary-Schaefer has received publishing royalties from a publication relating to health care. Dr. Foldvary-Schaefer has received publishing royalties from a publication relating to health care.
Iftekhar Ahmed, MD, PC, F�鶹��ýӳ��	Dr. Ahmed has nothing to disclose.
J. H. Harvey, DO	Dr. Harvey has received personal compensation for serving as an employee of Neuralogix. Dr. Harvey has received personal compensation for serving as an employee of Integris . Dr. Harvey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Harvey has stock in Epiminder.
Mason Leeman-Markowski, MD	Dr. Leeman-Markowski has nothing to disclose.
Olivia Thornburg	Olivia Thornburg has nothing to disclose.
Irene L. Katzan, MD	Dr. Katzan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring . The institution of Dr. Katzan has received research support from TEVA Pharmaceuticals.
Jocelyn B. Lorenzo, MD	Dr. Lorenzo has nothing to disclose.
Josephine Gutierrez, MD	No disclosure on file
L J. Greenfield, Jr., MD, PhD, F�鶹��ýӳ��	Dr. Greenfield has received publishing royalties from a publication relating to health care.
Rebecca O'Dwyer, MD	Dr. O'Dwyer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. O'Dwyer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK Life Sciences.
Stephen Hantus, MD	Dr. Hantus has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Hantus has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB.
Gregory Krauss, MD	Dr. Krauss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arvelle. Dr. Krauss has received stock or an ownership interest from EpiWatch.
Churl-Su Kwon, MBBS	Dr. Kwon has nothing to disclose.
Joana Moreira	Joana Moreira has received personal compensation for serving as an employee of BIAL.
Joseph Wiedemer	Mr. Wiedemer has nothing to disclose.
Eugen Trinka	Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GW Pharmaceuticals. The institution of Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rapport. The institution of Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. The institution of Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Eugen Trinka has received research support from European Union. Eugen Trinka has received publishing royalties from a publication relating to health care.
Vineet Punia, MD	Dr. Punia has nothing to disclose.
Jeremy D. Slater, MD, F�鶹��ýӳ��	Dr. Slater has received personal compensation for serving as an employee of Stratus. Dr. Slater has stock in Zeto LLC.
Wendy Chen, MD	Dr. Chen has nothing to disclose.
Kan Ding, MD	The institution of Dr. Ding has received research support from National Institute of Aging. The institution of Dr. Ding has received research support from NINDS.
Christopher P. Robinson, DO	Dr. Robinson has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for law firms.
Rebecca Stainman, MD	Dr. Stainman has nothing to disclose.
Andrea R. Lowden, MD	Dr. Lowden has nothing to disclose.
Corinne Allas	No disclosure on file
Diosely C. Silveira, MD, PhD, F�鶹��ýӳ��	Dr. Silveira has nothing to disclose.
Bassel W. Abou-Khalil, MD, F�鶹��ýӳ��	The institution of Dr. Abou-Khalil has received research support from Cerevel. The institution of Dr. Abou-Khalil has received research support from Xenon. The institution of Dr. Abou-Khalil has received research support from Otsuka. The institution of Dr. Abou-Khalil has received research support from UCB. The institution of Dr. Abou-Khalil has received research support from SK LIfe Science. The institution of Dr. Abou-Khalil has received research support from Neuroelectrics.
Dennis J. Dlugos, MD	Dr. Dlugos has received research support from NIH. The institution of Dr. Dlugos has received research support from The Epilepsy Study Consortium.
David G. Vossler, MD, F�鶹��ýӳ��	Dr. Vossler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Longboard Pharmaceuticals. Dr. Vossler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon Pharmaceuticals. Dr. Vossler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Science. The institution of Dr. Vossler has received research support from Xenon Pharmaceuticals. The institution of Dr. Vossler has received research support from Longboard Pharmaceuticals. Dr. Vossler has received publishing royalties from a publication relating to health care.
Abdullah Al Sawaf, MD	Dr. Al Sawaf has nothing to disclose.
Christian Brandt, MD	Dr. Brandt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. Dr. Brandt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW. Dr. Brandt has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Desitin. Dr. Brandt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arvelle. Dr. Brandt has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Brandt has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai. Dr. Brandt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zogenix. Dr. Brandt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GW. Dr. Brandt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Arvelle. The institution of Dr. Brandt has received research support from Rubin-Stiftung. Dr. Brandt has received publishing royalties from a publication relating to health care.
Musab Ali, MD	Dr. Ali has nothing to disclose.
Steven Gangloff, MD	Dr. Gangloff has nothing to disclose.
Jessica Falco-Walter, MD, F�鶹��ýӳ��	Dr. Falco-Walter has nothing to disclose.
Andrew Lin, MD	Dr. Lin has nothing to disclose.
Sohail A. Kamrudin, DO	Dr. Kamrudin has nothing to disclose.
Trudy Pang, MD	Dr. Pang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Stratus an Alliance Company.
Louis Ferrari	Louis Ferrari has received personal compensation for serving as an employee of SK Life science.
Salam M. Nasralla, MD	Dr. Nasralla has nothing to disclose.
Marian P. LaMonte, MD, MSN, F�鶹��ýӳ��	Dr. LaMonte has nothing to disclose.
Sean Hwang, MD	Dr. Hwang has nothing to disclose.
Eric Segal, MD	Dr. Segal has received personal compensation for serving as an employee of Lundbeck. Dr. Segal has received personal compensation for serving as an employee of Eisai. Dr. Segal has received personal compensation for serving as an employee of Neurelis. Dr. Segal has received personal compensation for serving as an employee of Zogenix. Dr. Segal has received personal compensation for serving as an employee of Aquestive. Dr. Segal has received personal compensation for serving as an employee of Greenwich Biosciences. Dr. Segal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Aquestive. Dr. Segal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Segal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Greenwhich Bioscience. Dr. Segal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Greenwhich Bioscience. Dr. Segal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelis.
Robert T. Wechsler, MD, PhD, F�鶹��ýӳ��	The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Otsuka. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Science. The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Aquestive. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Engage. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevel. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eisai. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sunovion. The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eliem. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epalex. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Engrail. The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Equilibre. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rapport. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurona. Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurelis. Dr. Wechsler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Sunovion. Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Wechsler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Greenwich/Jazz. Dr. Wechsler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eisai. Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aquestive. Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Science. Dr. Wechsler has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Epilepsy Studies Consortium. Dr. Wechsler has a non-compensated relationship as a Board President with Epilepsy Foundation of Idaho that is relevant to �鶹��ýӳ�� interests or activities.
Dietrich Haubenberger, MD, F�鶹��ýӳ��	Dr. Haubenberger has received personal compensation for serving as an employee of Neurocrine Biosciences, Inc. Dr. Haubenberger has stock in Neurocrine Biosciences. Dr. Haubenberger has a non-compensated relationship as a Member of the Board with American Society for Experimental Neurotherapeutics that is relevant to �鶹��ýӳ�� interests or activities.
Amanda Bingaman	Ms. Bingaman has nothing to disclose.
Stephanie C. Murti, DO	Ms. Murti has nothing to disclose.
Yao Cheng, MBBS	Dr. Cheng has nothing to disclose.
Paul V. Motika, MD	Dr. Motika has nothing to disclose.
Elizabeth Thiele, MD	Dr. Thiele has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GW Pharma/Jazz. Dr. Thiele has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for zogenix/UCB. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for nobelpharma. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for livanova. Dr. Thiele has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Noema Pharma. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for pyros pharmaceutical/upsher smith. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus Pharmaceuticals. The institution of Dr. Thiele has received research support from GW Pharma/Jazz. The institution of Dr. Thiele has received research support from Zogenix/UCB. The institution of Dr. Thiele has received research support from Stoke Therapeutics. The institution of Dr. Thiele has received research support from Biocodex. Dr. Thiele has received publishing royalties from a publication relating to health care.
Monica J. Goodman	Monica Goodman has nothing to disclose.
Dinesh Kumar	Dinesh Kumar has received personal compensation for serving as an employee of Eisai Inc.
Nicholas Thompson	The institution of Nicholas Thompson has received research support from EMD Serono.
Noam Butterfield, PhD	Dr. Butterfield has received personal compensation for serving as an employee of Xenon Pharmaceuticals.
Adam De Havenon, MD, F�鶹��ýӳ��	Dr. De Havenon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. De Havenon has or had stock in Certus.Dr. De Havenon has or had stock in TitinKM. The institution of Dr. De Havenon has received research support from NIH/NINDS. Dr. De Havenon has received publishing royalties from a publication relating to health care.
Michael Kentris, DO	Dr. Kentris has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for �鶹��ýӳ��.
Niravkumar Barot, MD	Dr. Barot has nothing to disclose.
Madeline C. Fields, MD	Dr. Fields has nothing to disclose.
Helena Gama	Helena Gama has received personal compensation for serving as an employee of Bial-Portela & Cª S.A..
Shawniqua Williams Roberson, MD	Dr. Williams Roberson has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Today. The institution of Dr. Williams Roberson has received research support from the National Institute on Aging. The institution of Dr. Williams Roberson has received research support from Brain & Behavior Research Foundation. The institution of Dr. Williams Roberson has received research support from National Institute on Mental Health . The institution of Dr. Williams Roberson has received research support from Ceribell, Inc.. Dr. Williams Roberson has received personal compensation in the range of $500-$4,999 for serving as a Visiting Speaker with University of Toronto.
Kanika Sharma, MD	Dr. Sharma has nothing to disclose.
Martin Rabe, MSc	Martin Rabe, M.Sc. has received personal compensation for serving as an employee of Eisai Inc.
Trevor J. Resnick, MD	Dr. Resnick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Resnick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for supernus. Dr. Resnick has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion.
Alexander Crossley	Mr. Crossley has nothing to disclose.
Saien Lai, MD	Dr. Lai has nothing to disclose.
Brian J. Hanrahan, MD	Dr. Hanrahan has received personal compensation for serving as an employee of Nowyouknow Neuro.
Guido D. Vazquez II, PhD	Dr. Vazquez has nothing to disclose.
Ryan Hays, MD, MBA, FAES, F�鶹��ýӳ��	Dr. Hays has nothing to disclose.
Olivia Groover, MD	Dr. Groover has nothing to disclose.
Evren Burakgazi, MD	Dr. Burakgazi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SK life Sciences. Dr. Burakgazi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelis.
Ronald Alvarado Dyer, MD	Dr. Alvarado Dyer has nothing to disclose.
Patrick K. Kwan, MD, PhD	No disclosure on file
Karina A. Gonzalez Otarula, MD	Dr. Gonzalez Otarula has nothing to disclose.
Veronica Campanille, MD	No disclosure on file
Hugh Simpson, MD, MBBS	Dr. Simpson has nothing to disclose.
Marisara Dieppa, MD	Dr. Dieppa has nothing to disclose.
Patricia E. Penovich, MD, F�鶹��ýӳ��	Dr. Penovich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Engage therapeutics. Dr. Penovich has received personal compensation in the range of $0-$499 for serving as a Consultant for LVIS. Dr. Penovich has received personal compensation in the range of $0-$499 for serving as a Consultant for Monteris. Dr. Penovich has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Therapeutics. Dr. Penovich has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. Dr. Penovich has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Greenwich. Dr. Penovich has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SK Biosciences. Dr. Penovich has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelis. Dr. Penovich has a non-compensated relationship as a Comittee Member with American Epilepsy Society that is relevant to �鶹��ýӳ�� interests or activities.
Jocelyn Y. Cheng, MD, F�鶹��ýӳ��	Dr. Cheng has received personal compensation for serving as an employee of Eisai Inc.
Wui Ho	Wui Ho has nothing to disclose.
Anika Morgado	Ms. Morgado has nothing to disclose.
Hernan Nicolas Lemus Esquivel, MD	Dr. Lemus Esquivel has nothing to disclose.
Nicholas Janocko, MD	Dr. Janocko has nothing to disclose.
Toufic Fakhoury, MD	Dr. Fakhoury has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB pharma. Dr. Fakhoury has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai . Dr. Fakhoury has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aquestive therapeutics. Dr. Fakhoury has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Fakhoury has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eisai. Dr. Fakhoury has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. The institution of Dr. Fakhoury has received research support from Xenon. The institution of Dr. Fakhoury has received research support from Takeda.
Hugh Jiwoong Lee	Hugh Jiwoong Lee has nothing to disclose.
Chokri A. Mhiri, MD	Prof. Mhiri has received personal compensation for serving as an employee of Hikma. Prof. Mhiri has received personal compensation for serving as an employee of Sanofi Genzyme. Prof. Mhiri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Prof. Mhiri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche.
Tracey Cho, MD, F�鶹��ýӳ��	Dr. Cho has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyverna. Dr. Cho has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Delve Bio. Dr. Cho has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. The institution of an immediate family member of Dr. Cho has received research support from NIH. Dr. Cho has received publishing royalties from a publication relating to health care.
Tina Liu, MD	Dr. Liu has nothing to disclose.
Brenda Auffinger, MD	Dr. Auffinger has nothing to disclose.
Ana Suller Marti, MD	Dr. Suller Marti has nothing to disclose.
Sang-Ahm Lee, MD	Dr. Lee has nothing to disclose.
Alfredo Thomson, MD	Dr. Thomson has nothing to disclose.
Deepti Chrusciel, MD	Dr. Chrusciel has nothing to disclose.
Mauricio F. Farez, MD	Dr. Farez has received personal compensation for serving as an employee of Entelai. Dr. Farez has stock in Entelai. The institution of Dr. Farez has received research support from Fundación Sadosky.
Kevan E. VanLandingham, MD, PhD, F�鶹��ýӳ��	Dr. VanLandingham has received personal compensation for serving as an employee of Greenwich Biosciences. Dr. VanLandingham has received stock or an ownership interest from Greenwich Biosciences.
Taha Gholipour, MD	Dr. Gholipour has nothing to disclose.
Chelsea Robalino	No disclosure on file
Vicente Villanueva	Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Angelini. Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon. Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rapport. Vicente Villanueva has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Vicente Villanueva has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Angelini. Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EISAI. Vicente Villanueva has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Paladin. Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz pharmaceutical.
Sunita Dergalust, PharmD	Ms. Dergalust has nothing to disclose.
Diane Teagarden, NP	Ms. Teagarden has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for livaNova. Ms. Teagarden has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neuropace.
Babak Razavi, MD, PhD	Dr. Razavi has stock in CortexXus. The institution of Dr. Razavi has received research support from Neuropace.
Anil Chimakurthy, MD	Dr. Chimakurthy has nothing to disclose.
Amir Karimi	No disclosure on file
Jon T. Willie, MD, PhD	Jon T. Willie, MD, PhD has received personal compensation in the range of $0-$499 for serving as a Consultant for AiM Medical. Jon T. Willie, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Medtronic. Jon T. Willie, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neuropace.
Ioannis Karakis, MD, F�鶹��ýӳ��	Dr. Karakis has received personal compensation for serving as an employee of Emory University School of Medicine. Dr. Karakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Karakis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GSK. Dr. Karakis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Epitel. Dr. Karakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Karakis has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Hill Ward Henderson.
Danielle S. McDermott, MD	The institution of Dr. McDermott has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Marinus Pharmaceuticals . Dr. McDermott has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK biosciences .
Rachel Gorenflo	Rachel Gorenflo has nothing to disclose.
Andrew Trigg	Andrew Trigg has received personal compensation for serving as an employee of Adelphi Values.
Ibrahim Mustafa, MD	Dr. Mustafa has nothing to disclose.
Mansi B. Parekh, PhD	Dr. Parekh has received personal compensation for serving as an employee of Neurona Therapeutics.
Celene Grayson, PhD	Dr. Grayson has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. Dr. Grayson has stock in Xenon Pharmaceuticals Inc..
Vicki A. Ramsey-Williams, MD, PhD	Dr. Ramsey-Williams has nothing to disclose.
Rahul Khanna, MBBS	Dr. Khanna has nothing to disclose.
Ahmad A. Ballout, MD	Dr. Ballout has nothing to disclose.
Maria J. Bruzzone, MD, F�鶹��ýӳ��	Dr. Bruzzone has nothing to disclose.
John M. Schreiber, MD	Dr. Schreiber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Schreiber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon. Dr. Schreiber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zogenix. The institution of Dr. Schreiber has received research support from Dravet Syndrome Foundation.
Hans Klein, PhD	Hans Klein has received personal compensation for serving as an employee of Stratus.
Jordan Seliger	Jordan Seliger has nothing to disclose.
John Thompson	John Thompson has nothing to disclose.
Mohamed Tom, MD	Dr. Tom has received personal compensation for serving as an employee of Allegheny General Hospital . Dr. Tom has received personal compensation for serving as an employee of Mercy Hospital St. Louis .
Jerome Engel, Jr., MD, PhD, F�鶹��ýӳ��	Dr. Engel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerebel. Dr. Engel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Engel has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink. Dr. Engel has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Steven Barris. Dr. Engel has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Cutler Law Firm. Dr. Engel has received publishing royalties from a publication relating to health care. Dr. Engel has received publishing royalties from a publication relating to health care. Dr. Engel has received publishing royalties from a publication relating to health care. Dr. Engel has received publishing royalties from a publication relating to health care.
Hongyan Li, MD, PhD, F�鶹��ýӳ��	Dr. Li has nothing to disclose.
Peter B. Forgacs, MD	Dr. Forgacs has received personal compensation for serving as an employee of Xenon Pharmaceuticals. Dr. Forgacs has or had stock in Xenon Pharmaneuticals.
Mohanad A. AlGaeed, MD	Dr. AlGaeed has nothing to disclose.
Page B. Pennell, MD, F�鶹��ýӳ��	The institution of Dr. Pennell has received research support from NIH.
Enrique Carrazana	Enrique Carrazana has received personal compensation for serving as an employee of Neurelis. Enrique Carrazana has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Hawaii-Biotech, CND Life Sciences, Apex Labs. Enrique Carrazana has stock in Neurelis, CND, Apex.
Rodrigo Zepeda, MD	The institution of Dr. Zepeda has received research support from NIH.
James D. Triplett, MBBS	Dr. Triplett has nothing to disclose.
R. E. Ramsay, MD	Dr. Ramsay has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alliance Family of Companies. Dr. Ramsay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. Dr. Ramsay has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sunovion. Dr. Ramsay has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Ramsay has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK Life Sci.
Patrick Kwan	Patrick Kwan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EDUCOM SPA. Patrick Kwan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Patrick Kwan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. The institution of Patrick Kwan has received research support from UCB. The institution of Patrick Kwan has received research support from Eisai.
Robyn Busch	Robyn Busch has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier Inc.. Robyn Busch has received research support from National Institutes of Health. Robyn Busch has received research support from American Epilepsy Society. Robyn Busch has received research support from Cleveland Clinic. Robyn Busch has received research support from Ohio Department of Higher �鶹��ýӳ��. Robyn Busch has received intellectual property interests from a discovery or technology relating to health care.
Cynthia L. Harden, MD	Dr. Harden has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. Dr. Harden has stock in Xenon Pharmaceuticals Inc.. Dr. Harden has received intellectual property interests from a discovery or technology relating to health care.
Kimford J. Meador, MD, F�鶹��ýӳ��	The institution of Dr. Meador has received research support from NIH. The institution of Dr. Meador has received research support from The Epilepsy Consortium.
Sidra Saleem, MD	Dr. Saleem has nothing to disclose.
Omar N. Nofal, MD	Dr. Nofal has nothing to disclose.
Shafali Jeste, MD, F�鶹��ýӳ��	Dr. Jeste has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche Pharmaceuticals. Dr. Jeste has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Pharmaceuticals. Dr. Jeste has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis Pharmaceuticals. Dr. Jeste has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for �鶹��ýӳ�� Continuum. The institution of Dr. Jeste has received research support from NIH. The institution of Dr. Jeste has received research support from DoD. The institution of Dr. Jeste has received research support from Dup15q Alliance.
Alise K. Carlson, MD	Dr. Carlson has received research support from Biogen (fellowship grant 16696-P-FEL).
Amitabh Dash, MD	Amitabh Dash, MD has nothing to disclose.
Marina K. Alvim	Dr. Alvim has nothing to disclose.
Ahmed Abbas, MD	Dr. Abbas has nothing to disclose.
Lauren B. Fine, PA	Mrs. Fine has nothing to disclose.
Julia Bodnya, MD	Dr. Bodnya has nothing to disclose.
Bradley Lega, MD	The institution of Bradley Lega has received research support from NIH.
Vaclav Kremen	Vaclav Kremen has nothing to disclose.
Dave F. Cook	No disclosure on file
Claude G. Wasterlain, MD, F�鶹��ýӳ��	The institution of Dr. Wasterlain has received research support from Eisai. Dr. Wasterlain has received publishing royalties from a publication relating to health care.
Imad M. Najm, MD	Dr. Najm has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai Inc. Dr. Najm has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai Inc. Dr. Najm has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eisai Inc.
Clarissa L. Yasuda, MD, PhD	Prof. Yasuda has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for LIBBS. Prof. Yasuda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBOTT. Prof. Yasuda has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for LIBBS.
Abril Marone, MD	Dr. Marone has nothing to disclose.
santiago Claverie	santiago Claverie has nothing to disclose.
Marc Kamin, MD	Dr. Kamin has received personal compensation for serving as an employee of SK LIFE SCIENCE INC.
Alexander Doyle, MD	Dr. Doyle has nothing to disclose.
Marie C. Eugene, DO, MSHPE, F�鶹��ýӳ��	Dr. Eugene has nothing to disclose.
Niyatee Samudra, MD	Dr. Samudra has nothing to disclose.
Michael C. Irizarry, MD	Dr. Irizarry has received personal compensation for serving as an employee of Eisai, Inc..
Manuel Toledo	Manuel Toledo has nothing to disclose.
Pouria A. Koushesh	Mr. Koushesh has nothing to disclose.
Ammar Tarabichi, MD	Dr. Tarabichi has nothing to disclose.
Mindy Grall, PhD, NP	Ms. Grall has received personal compensation for serving as an employee of Supernus Pharmaceuticals. Ms. Grall has or had stock in Supernus.
Kourosh Rezania, MD, F�鶹��ýӳ��	Dr. Rezania has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Akcea. Dr. Rezania has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alnylam.
Ahyuda Oh, PhD	Dr. Oh has nothing to disclose.
Fabio Ikedo	Fabio Ikedo has received personal compensation for serving as an employee of Bial.
Elizabeth Cunningham	Elizabeth Cunningham has nothing to disclose.
Deepak K. Lachhwani, MD, F�鶹��ýӳ��	The institution of Dr. Lachhwani has received research support from ICON Clinical Research LLC.
Caroline Kim, Pharmacist	Caroline Kim has nothing to disclose.
Dileep R. Nair, MD	Dr. Nair has nothing to disclose.
Robert Gross	No disclosure on file
Ian T. Coulter, MD	Dr. Coulter has nothing to disclose.
Alejandro Salah, MD, PhD, MBA, MHA	Dr. Salah has received personal compensation for serving as an employee of Mitsubishi Tanabe Pharma.
Uma Menon, MD, MBA, F�鶹��ýӳ��	Dr. Menon has nothing to disclose.
Anna McDonnell	Mrs. McDonnell has nothing to disclose.
Mohammed A. ElSherif, MD, PhD, F�鶹��ýӳ��	Dr. ElSherif has nothing to disclose.
Ricardo D. Bernater	No disclosure on file
Patrick Landazuri, MD, F�鶹��ýӳ��	Dr. Landazuri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuropace. Dr. Landazuri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuropace. Dr. Landazuri has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Federal Public Defender - District of Kansas. Dr. Landazuri has received publishing royalties from a publication relating to health care.
Katherine Werbaneth, MD	Dr. Werbaneth has nothing to disclose.
Faddi G. Saleh Velez, MD	Dr. Saleh Velez has nothing to disclose.
Majed Alzahrany, MBBS	Dr. Alzahrany has nothing to disclose.
Asia Payne, MD	Ms. Payne has nothing to disclose.
Sotiris G. Mitropanopoulos, MD	Dr. Mitropanopoulos has nothing to disclose.
Yazan Nofal, MD	Dr. Nofal has nothing to disclose.
Rebecca E. Matthews, MD	Dr. Matthews has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Penry Epilepsy Programs.
Haley Phillips, MD	Dr. Phillips has nothing to disclose.
Cory R. Nicholas, PhD	Dr. Nicholas has received personal compensation for serving as an employee of Neurona Therapeutics. Dr. Nicholas has stock in Neurona Therapeutics. Dr. Nicholas has received intellectual property interests from a discovery or technology relating to health care.
Catherine Priest, PhD	Catherine Priest has received personal compensation for serving as an employee of Neurona Therapeutics. Catherine Priest has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novo Nordisk. The institution of Catherine Priest has received research support from CIRM.
Helaina Lehrer, MD	Dr. Lehrer has nothing to disclose.
Jeffrey W. Britton, MD, F�鶹��ýӳ��	Dr. Britton has received personal compensation in the range of $0-$499 for serving as a Online course with American Clinical Neurophysiology Society.
Luis Fuentealba	Luis Fuentealba has nothing to disclose.
Amy Nowacki	Amy Nowacki has nothing to disclose.
Luis Magalhaes	Luis Magalhaes has received personal compensation for serving as an employee of BIAL-Portela & Cª, S.A..
Michael R. Sperling, MD, F�鶹��ýӳ��	Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. The institution of Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medscape. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for International Medical Press. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Projects for Knowledge. The institution of Dr. Sperling has received research support from SK Life Science. The institution of Dr. Sperling has received research support from UCB Pharma . The institution of Dr. Sperling has received research support from Takeda. The institution of Dr. Sperling has received research support from Neurelis. The institution of Dr. Sperling has received research support from Engage Therapeutics . The institution of Dr. Sperling has received research support from Medtronic. The institution of Dr. Sperling has received research support from Cavion. The institution of Dr. Sperling has received research support from Xenon Pharma. The institution of Dr. Sperling has received research support from Cerevel. The institution of Dr. Sperling has received research support from National Institutes of Health . The institution of Dr. Sperling has received research support from DARPA. Dr. Sperling has received publishing royalties from a publication relating to health care. Dr. Sperling has received publishing royalties from a publication relating to health care. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Vice President with Epilepsy Consortium .
Nataliya Pyatka, MD	Dr. Pyatka has nothing to disclose.
Robert Flamini, MD	Dr. Flamini has received personal compensation in the range of $0-$499 for serving as a Consultant for Biocodex. Dr. Flamini has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Dr. Flamini has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals.
Siddhika Sreenivasan	No disclosure on file
Tze-Chiang Meng	Tze-Chiang Meng has received personal compensation for serving as an employee of Proximagen, LLC. An immediate family member of Tze-Chiang Meng has a non-compensated relationship as a Stockholder with Abbott Laboratories that is relevant to �鶹��ýӳ�� interests or activities. An immediate family member of Tze-Chiang Meng has a non-compensated relationship as a Stockholder with Johnson & Johnson that is relevant to �鶹��ýӳ�� interests or activities. An immediate family member of Tze-Chiang Meng has a non-compensated relationship as a Stockholder with Medtronic that is relevant to �鶹��ýӳ�� interests or activities. Tze-Chiang Meng has a non-compensated relationship as a Stockholder with 3M that is relevant to �鶹��ýӳ�� interests or activities.
Ian Miller, MD	Dr. Miller has received personal compensation for serving as an employee of Marinus Pharmaceuticals. Dr. Miller has stock in Marinus Pharmaceuticals.
Brad K. Kamitaki, MD	Dr. Kamitaki has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brown and Brown Absence Services Group. The institution of Dr. Kamitaki has received research support from New Jersey Health Foundation. The institution of Dr. Kamitaki has received research support from National Institute on Aging.
Fatima Zuberi, MD, BA	Fatima Zuberi has nothing to disclose.
Vishal Shah, MBBS, F�鶹��ýӳ��	Dr. Shah has nothing to disclose.
Steven P. Sparagana, MD, F�鶹��ýӳ��	Dr. Sparagana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Greenwich Biosciences. Dr. Sparagana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nobelpharma. The institution of Dr. Sparagana has received research support from Greenwich Biosciences. The institution of Dr. Sparagana has received research support from Tuberous Sclerosis Alliance. The institution of Dr. Sparagana has received research support from Novartis. Dr. Sparagana has a non-compensated relationship as a Professional Advisory Board Member, committee member with Tuberous Sclerosis Alliance that is relevant to �鶹��ýӳ�� interests or activities.
Luiz E. Betting	Dr. Betting has nothing to disclose.
Richard McLachlan, MD	No disclosure on file
Salman Tarique, MD	Dr. Tarique has nothing to disclose.
John M. Stern, MD, F�鶹��ýӳ��	Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Science. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharma. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for LivaNova. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for LivaNova. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences. Dr. Stern has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Stern has stock in DEARhealth. Dr. Stern has stock in Ceribell. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care.
Kyra Curtis, MD	Ms. Curtis has nothing to disclose.
J B. Renfroe, MD	Dr. Renfroe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Engage Therapeutics. Dr. Renfroe has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eisai. Dr. Renfroe has received intellectual property interests from a discovery or technology relating to health care.
Mark Agostini, MD	Dr. Agostini has nothing to disclose.
Aakriti Kothiwal	Dr. Kothiwal has nothing to disclose.
Kamil Detyniecki, MD	Dr. Detyniecki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aquestive. Dr. Detyniecki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Detyniecki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Detyniecki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Greenwich.
Anup D. Patel, MD, F�鶹��ýӳ��	Dr. Patel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. The institution of Dr. Patel has received research support from PCORI. Dr. Patel has received personal compensation in the range of $10,000-$49,999 for serving as a Webinar Development with Medscape. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving as a Other capacity with Guidepoint. Dr. Patel has a non-compensated relationship as a Chair Quality Committee with �鶹��ýӳ�� that is relevant to �鶹��ýӳ�� interests or activities. Dr. Patel has a non-compensated relationship as a Committee Member with Child Neurology Society that is relevant to �鶹��ýӳ�� interests or activities. Dr. Patel has a non-compensated relationship as a Board of Directors - member with �鶹��ýӳ�� Institute that is relevant to �鶹��ýӳ�� interests or activities.
Ali A. Fadhil, MD	Dr. Fadhil has nothing to disclose.
Anne M. Comi, MD	Dr. Comi has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Greenwich Biosciences. The institution of Dr. Comi has received research support from Greenwich Biosciences. The institution of Dr. Comi has received research support from Celebrate Hope Foundation. The institution of Dr. Comi has received research support from Faneca 66 Foundation. Dr. Comi has received intellectual property interests from a discovery or technology relating to health care.
Jean E. Cibula, MD, F�鶹��ýӳ��	Dr. Cibula has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medical Information Group. Dr. Cibula has received stock or an ownership interest from Merck. Dr. Cibula has received stock or an ownership interest from 3M. Dr. Cibula has received stock or an ownership interest from Steris. Dr. Cibula has received stock or an ownership interest from Baxter. The institution of Dr. Cibula has received research support from UCB Pharma.
Anto Bagic, MD, PhD	Dr. Bagic has nothing to disclose.
Tony Wu, MD, PhD	Dr. Wu has nothing to disclose.
Jay Salpekar	No disclosure on file
Abby Begezda, MD	Ms. Begezda has nothing to disclose.
Prasannakumar K. Gajera, MBBS	Dr. Gajera has nothing to disclose.
Daniel C. Tarquinio, DO	The institution of Dr. Tarquinio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis.
Biju Gopalakrishnan, MD, MBBS, DM	Dr. Gopalakrishnan has nothing to disclose.
Sameer Sharma, MD, MBBS	Dr. Sharma has nothing to disclose.
Ramsha A. Bhutta, MD	Dr. Bhutta has nothing to disclose.
Vibhor Krishna	No disclosure on file
Fawad A. Khan, MD	The institution of Dr. Khan has received research support from Amgen .
Carla F. Bolano Diaz, MD	Dr. Bolano Diaz has nothing to disclose.
Wesley Kerr, MD, PhD	Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Science. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven Pharmaceuticals. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurelis. Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for QurAlis. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven Pharmaceuticals. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. The institution of Dr. Kerr has received research support from NINDS. The institution of Dr. Kerr has received research support from American Epilepsy Society. The institution of Dr. Kerr has received research support from �鶹��ýӳ��. The institution of Dr. Kerr has received research support from SK Life Science. The institution of Dr. Kerr has received research support from Biohaven Pharmaceuticals. Dr. Kerr has received publishing royalties from a publication relating to health care.
Yara Mikhaeil-Demo, MD	Dr. Mikhaeil-Demo has nothing to disclose.
Nazanin Sheibani, MD	Dr. Sheibani has nothing to disclose.
Alison Cutts	Alison Cutts has received personal compensation for serving as an employee of Xenon Pharmaceuticals. Alison Cutts has or had stock in Xenon Pharmaceuticals.Alison Cutts has received intellectual property interests from a discovery or technology relating to health care.
Hyunmi Kim, MD	Dr. Kim has nothing to disclose.
Wentao Li, MD	Dr. Li has nothing to disclose.
Russell P. Saneto, DO, PhD	Dr. Saneto has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for REATA. Dr. Saneto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GW Pharmaceuticals. The institution of Dr. Saneto has received research support from NIH. The institution of Dr. Saneto has received research support from Zogenix. The institution of Dr. Saneto has received research support from GW Pharmaceuticals.
Parakash Pratibhu, MD	Dr. Pratibhu has nothing to disclose.
Rohit Das, MD, F�鶹��ýӳ��	Dr. Das has received personal compensation for serving as an employee of Oregon Health Science University. Dr. Das has received personal compensation in the range of $10,000-$49,999 for serving as a Physician Advisor with Concentra .
Lynn Liu, MD, F�鶹��ýӳ��	Dr. Liu has nothing to disclose.
Rohit Shankar	Rohit Shankar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Rohit Shankar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. The institution of Rohit Shankar has received research support from eisai. The institution of Rohit Shankar has received research support from UCB. The institution of Rohit Shankar has received research support from LivaNova. The institution of Rohit Shankar has received research support from GW pharma. The institution of Rohit Shankar has received research support from NIHR. The institution of Rohit Shankar has received research support from SBRI.
Aissata Diawara, MD	Dr. Diawara has nothing to disclose.
Michael C. Smith, MD, F�鶹��ýӳ��	Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SK Lifesciences. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SK Lifesciences .
Cecil D. Hahn, MD	Dr. Hahn has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda Pharmaceuticals. Dr. Hahn has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Holberg EEG. Dr. Hahn has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Hahn has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pendopharm. Dr. Hahn has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neurophysiology. Dr. Hahn has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for various legal firms. Dr. Hahn has received publishing royalties from a publication relating to health care. Dr. Hahn has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with CADTH.
Jorge G. Burneo, MD, MSPH, F�鶹��ýӳ��	Dr. Burneo has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier, Clinical Neurology and Neurosurgery Journal. Dr. Burneo has received research support from The Jack Cowin Endowed Chair in Epilepsy Research. Dr. Burneo has received publishing royalties from a publication relating to health care. Dr. Burneo has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Jazz Pharmaceuticals.
Harshad Ladha, MD	Dr. Ladha has nothing to disclose.
Pravin George, DO	Dr. George has nothing to disclose.
Miguel Arevalo Astrada	Miguel Arevalo Astrada has nothing to disclose.
Masud Seyal, MD, PhD, F�鶹��ýӳ��	Dr. Seyal has nothing to disclose.
Manjot Grewal, MD	Dr. Grewal has nothing to disclose.
Jillian Rosengard, MD	Dr. Rosengard has nothing to disclose.
Guadalupe Fernandez-Baca Vaca, MD	Dr. Fernandez-Baca Vaca has nothing to disclose.
Cynthia Guerra	Cynthia Guerra has received personal compensation for serving as an employee of Neurelis, Inc. Cynthia Guerra has received stock or an ownership interest from Neurelis Inc.
Katrina Roberto, MD	Dr. Roberto has nothing to disclose.
Aida Risman, MD	Dr. Risman has nothing to disclose.
Anne T. Berg, PhD	Dr. Berg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven. Dr. Berg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Berg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Encoded. Dr. Berg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biomarin. The institution of Dr. Berg has received research support from FamilieSCN2A Foundation.
Anum H. Riaz, MD	Dr. Riaz has nothing to disclose.
David W. Loring, PhD, F�鶹��ýӳ��	Dr. Loring has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. Dr. Loring has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ILAE. The institution of Dr. Loring has received research support from NIH. Dr. Loring has received publishing royalties from a publication relating to health care.
Hira Pervez, MD, MBBS	Dr. Pervez has nothing to disclose.
Gayane R. Melikyan, MD, F�鶹��ýӳ��	Dr. Melikyan has nothing to disclose.
Sima I. Patel, MD	Dr. Patel has nothing to disclose.
Chang Shek Kwan, MD	Dr. Kwan has nothing to disclose.
Steven C. Schachter, MD, F�鶹��ýӳ��	Dr. Schachter has received personal compensation in the range of $0-$499 for serving as a Consultant for Supernus Pharmaceuticals. Dr. Schachter has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Schachter has received intellectual property interests from a discovery or technology relating to health care. Dr. Schachter has received publishing royalties from a publication relating to health care. Dr. Schachter has received publishing royalties from a publication relating to health care.
Jose A. Montes-Rivera, MD, F�鶹��ýӳ��	Dr. Montes-Rivera has nothing to disclose.
Arooj Kohli, MD	Dr. Kohli has nothing to disclose.
Carlos Perdomo	No disclosure on file
Busranur Agac, MD	Dr. Agac has nothing to disclose.
Prashant K. Rai, MD	Dr. Rai has nothing to disclose.
Mayur Chalia, MD	Dr. Chalia has nothing to disclose.
Lara Jehi, MD	Dr. Jehi has nothing to disclose.
Gustavo A. Patino, MD, PhD	Dr. Patino has nothing to disclose.
Sasha Alick-Lindstrom, MD, MPH FACNS, FAES, F�鶹��ýӳ��	Dr. Alick-Lindstrom has nothing to disclose.
Melinda S. Martin, PhD	Dr. Martin has received personal compensation for serving as an employee of UCB. Dr. Martin has or had stock in UCB.
Patrick Arraj	Mr. Arraj has nothing to disclose.
Paul Lyons, MD	Dr. Lyons has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Lyons has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals .
Atul Maheshwari, MD	Dr. Maheshwari has nothing to disclose.
Kelsey Sewell	Kelsey Sewell has nothing to disclose.
Jamie A. Simpson	Mr. Simpson has nothing to disclose.
Ronald L. Thibert, DO	Dr. Thibert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ovid Pharmaceuticals.
Alicia Gonzalez-Martinez, MD	Dr. Gonzalez-Martinez has nothing to disclose.
Guiyun Wu, MD	Dr. Wu has nothing to disclose.
Jafar Hashem, MD	Dr. Hashem has nothing to disclose.
Natália d. Fim Nakao, MD	Natália Fim Nakao has nothing to disclose.
Pavel Klein, MD, F�鶹��ýӳ��	The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Aquestive. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurelis. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Sience. The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alliance. The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arvelle Therapeutics. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Aquestive. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai. Dr. Klein has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Klein has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for SK Life Sciences. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sunovion. Dr. Klein has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for PrevEp. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Fenwick . Dr. Klein has received research support from DOD/CURE.
Manoj Malhotra, MD	Dr. Malhotra has received personal compensation for serving as an employee of Eisai.
Ifrah Zawar, MD	The institution of Dr. Zawar has received research support from Alzheimer's association. The institution of Dr. Zawar has received research support from American epilepsy society . The institution of Dr. Zawar has received research support from NIH. The institution of Dr. Zawar has received research support from University of Virginia.
Seyed M. Mirsattari, MD, PhD, FRCPC	Dr. Mirsattari has nothing to disclose.
Lynn D. Kramer, MD, F�鶹��ýӳ��	Dr. Kramer has received personal compensation for serving as an employee of Eisai Inc. Dr. Kramer has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Eisai Co., Ltd..
Francis M. Filloux, MD	Dr. Filloux has nothing to disclose.
Takamichi Yamamoto, MD, PhD, FAES	Dr. Yamamoto has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eisai. Dr. Yamamoto has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Daiichi-Sankyo.
Taoufik Alsaadi, MD, F�鶹��ýӳ��	Dr. Alsaadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Alsaadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Alsaadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Alsaadi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. Dr. Alsaadi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pfizer. Dr. Alsaadi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GSK. The institution of Dr. Alsaadi has received research support from Novartis. The institution of Dr. Alsaadi has received research support from Abbvie. The institution of Dr. Alsaadi has received research support from Pfizer.
Ji-Yeoun Yoo, MD	Dr. Yoo has received publishing royalties from a publication relating to health care.
Jenan N. Shukry, MD	Dr. Shukry has nothing to disclose.
Blake Newman, MD	Dr. Newman has nothing to disclose.
Ryan Edbert Husni	Ryan Edbert Husni has received personal compensation for serving as an employee of Eisai, Co. Ltd. Ryan Edbert Husni has received personal compensation in the range of $500-$4,999 for serving as a Foreign Scholar with Japan Ministry of �鶹��ýӳ��, Culture, Sports, Science and Technology (MEXT).
Denise Li, MD	Dr. Li has nothing to disclose.
Wendyl J. D'Souza, MD, MBChB	Dr. D'Souza has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LivaNova, Eisai, UCB, Tilray. Dr. D'Souza has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB Pharma, Eisai Pharmaceutical. Dr. D'Souza has stock in Epiminder. The institution of Dr. D'Souza has received research support from UCB Pharma. The institution of Dr. D'Souza has received research support from Eisai Pharmaceutical.
Christopher R. Newey, DO	Dr. Newey has nothing to disclose.
Arkady Nisman, PharmD	Dr. Nisman has received personal compensation for serving as an employee of SK Life Science, Inc.. Dr. Nisman has a non-compensated relationship as a Senior Director, Medical Affairs with SK Life Science, Inc. that is relevant to �鶹��ýӳ�� interests or activities.
Clio A. Rubinos, MD, MSCR	Dr. Rubinos has nothing to disclose.
Navkiranjot Kaur	Ms. Kaur has nothing to disclose.
Abdulrahman Alwaki, MD	Dr. Alwaki has nothing to disclose.
Aaron L. Nelson, MD, F�鶹��ýӳ��	Dr. Nelson has nothing to disclose.
Ndubuisi Ahuruonye, MD	Dr. Ahuruonye has nothing to disclose.
Erin M. Okazaki, MD	Dr. Okazaki has nothing to disclose.
Nitin Agarwal, MBBS	Dr. Agarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai Inc.
Gregory D. Cascino, MD, F�鶹��ýӳ��	Dr. Cascino has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International League Against Epilepsy . Dr. Cascino has received intellectual property interests from a discovery or technology relating to health care. Dr. Cascino has received publishing royalties from a publication relating to health care. Dr. Cascino has received publishing royalties from a publication relating to health care.
Gary D. Clark, MD	The institution of Dr. Clark has received research support from Greewich pharmaceuticals. The institution of Dr. Clark has received research support from Novartis.
Adrian I. Espiritu, MD	Dr. Espiritu has nothing to disclose.
Jay D. Desai, MD	Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aquestive. The institution of Dr. Desai has received research support from Neurelis, Aquestive, Ovid, Novartis, UCB.
Bryan D. Clements II, DO	Dr. Clements has nothing to disclose.
Joseph F. Drazkowski, MD, F�鶹��ýӳ��	Dr. Drazkowski has nothing to disclose.
Prashant Natteru, MBBS	Dr. Natteru has nothing to disclose.
Perminder Bhatia, MD	Dr. Bhatia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BIOHAVEN. Dr. Bhatia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ALLERGAN. Dr. Bhatia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SK LIFE SCIENCES.
Cigdem I. Akman, MD	Dr. Akman has nothing to disclose.
Min Ye Shen, MD	Dr. Shen has nothing to disclose.
Eric p. Yeager, MD	Mr. Yeager has nothing to disclose.
Nathalie Jette, MD, MSc, FRCPC, F�鶹��ýӳ��	Dr. Jette has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ILAE Epilepsia. The institution of Dr. Jette has received research support from NIH. The institution of Dr. Jette has received research support from AES.
Aasef Shaikh, MD	Dr. Shaikh has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda.
Guy M. McKhann, MD	No disclosure on file
Eric Jen	Eric Jen has received personal compensation for serving as an employee of Neurocrine Biosciences, Inc.
Brian Toh	Brian Toh has nothing to disclose.
Irina Podkorytova	Irina Podkorytova has nothing to disclose.
Jamie J. Van Gompel, MD	Jamie J. Van Gompel, MD has stock in Neuroone.
Tara T. Lineweaver, MD	Dr. Lineweaver has nothing to disclose.
William C. Leung, MBBS, MRCP, FHKAM	Dr. Leung has nothing to disclose.
Dianalee McKnight, PhD	Dr. McKnight has nothing to disclose.
Carolyn Tsai, MD	Dr. Tsai has nothing to disclose.
Gregory A. Worrell, MD	Dr. Worrell has received stock or an ownership interest from NeuroOne Inc.. Dr. Worrell has received stock or an ownership interest from Cadence Neuroscience Inc. The institution of Dr. Worrell has received research support from NIH. The institution of Dr. Worrell has received research support from Medtronic Inc.. The institution of Dr. Worrell has received research support from Neuropace Inc,. The institution of Dr. Worrell has received research support from Epilepsy Foundation of America. Dr. Worrell has received intellectual property interests from a discovery or technology relating to health care. Dr. Worrell has received intellectual property interests from a discovery or technology relating to health care.
Pradeep Chandan, DO	Dr. Chandan has nothing to disclose.
Dagmar Amtmann	The institution of Dagmar Amtmann has received research support from Zogenix .
Sami M. Aboumatar, MD	Dr. Aboumatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Aboumatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SK Life Science, Inc.. Dr. Aboumatar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Aboumatar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion.
Maria Jaramillo, MD	Dr. Jaramillo has nothing to disclose.
Sara Dawit, MD	Dr. Dawit has nothing to disclose.
Lindsay Kimball	Lindsay Kimball has nothing to disclose.
Felippe Borlot, MD	Dr. Borlot has nothing to disclose.
Shreya Louis, MD, MS	Dr. Louis has nothing to disclose.
Marissa Kellogg, MD, MPH, F�鶹��ýӳ��	The institution of Dr. Kellogg has received research support from VA & DoD.
Andreas V. Alexopoulos, MD, MPH	Dr. Alexopoulos has nothing to disclose.
Heather Lau, MD	Dr. Lau has received personal compensation for serving as an employee of Ultragenyx. Dr. Lau has or had stock in Ultragenyx.
Daniel Drane, PhD	Dr. Drane has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Medical Directors Solutions, Inc. The institution of Dr. Drane has received research support from NIH/NINDS. The institution of Dr. Drane has received research support from Medtronic, Inc..
Matthew L. Morton, MD	Dr. Morton has nothing to disclose.
Stephan Schuele, MD, F�鶹��ýӳ��	Dr. Schuele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris. Dr. Schuele has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelis. Dr. Schuele has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Science. Dr. Schuele has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz. Dr. Schuele has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neurophysiology. Dr. Schuele has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Thomas Needham. Dr. Schuele has received research support from National Institute of Health.
James F. Castellano, MD, PhD	Dr. Castellano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuro One medical technologies. The institution of Dr. Castellano has received research support from NIH. The institution of Dr. Castellano has received research support from University of Pittsburgh.
Fernando Cendes, MD, PhD, F�鶹��ýӳ��	Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Biopharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for United Medical – Brazil. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zodiac Pharma . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eurofarma – Brazil . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology - Epilepsy. The institution of Dr. Cendes has received research support from São Paulo Research Foundation - FAPESP. The institution of Dr. Cendes has received research support from Conselho Nacional de Desenvolvimento Científico e Tecnológico - Brazil . The institution of Dr. Cendes has received research support from NIH.
Ghazala Perven, MD	Dr. Perven has nothing to disclose.
E M. Bebin, MD, F�鶹��ýӳ��	Dr. Bebin has received personal compensation for serving as an employee of Springworks Therapeutics. Dr. Bebin has received personal compensation for serving as an employee of Apertura Gene Therapy. Dr. Bebin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springworks Therapeutics. Dr. Bebin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Apertura. The institution of Dr. Bebin has received research support from NINDS. The institution of Dr. Bebin has received research support from FDA Orphan Drug Program.
Jesse W. Mindel, MD	Dr. Mindel has nothing to disclose.
Cecilia Peterson	An immediate family member of Ms. Peterson has received personal compensation for serving as an employee of 100Plus.
David E. Blum, MD	Dr. Blum has received personal compensation for serving as an employee of Neurona Therapeutics. Dr. Blum has stock in Neurona Therapeutics.
Peter Van Ess	Peter Van Ess has received personal compensation for serving as an employee of Proximagen.
Angela K. Birnbaum, PhD	The institution of Dr. Birnbaum has received research support from National Institutes of Health. The institution of Dr. Birnbaum has received research support from Randy Shaver Cancer and Research Foundation. Dr. Birnbaum has received intellectual property interests from a discovery or technology relating to health care.
Franco E. Appiani, MD	Dr. Appiani has nothing to disclose.
William E. Rosenfeld, MD, F�鶹��ýӳ��	The institution of Dr. Rosenfeld has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for SK Life Science. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Science.
Jena Grauer	No disclosure on file
Leon A. Weinstock, MD	Dr. Weinstock has nothing to disclose.
Katherine Liao, PharmD	Dr. Liao has nothing to disclose.
Benjamin H. Brinkmann, PhD	Dr. Brinkmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Dr. Brinkmann has stock in Cadence Neuroscience. The institution of Dr. Brinkmann has received research support from Epilepsy Foundation of America. The institution of Dr. Brinkmann has received research support from National Institutes of Health. The institution of Dr. Brinkmann has received research support from National Institutes of Health. The institution of Dr. Brinkmann has received research support from UNEEG A/S. The institution of Dr. Brinkmann has received research support from Seer Medical Pty. The institution of Dr. Brinkmann has received research support from Neurelis Inc. Dr. Brinkmann has received intellectual property interests from a discovery or technology relating to health care.
Imran I. Ali, MD, F�鶹��ýӳ��	Dr. Ali has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for ABPN.
Prashant Dongre, MD, MBBS	Dr. Dongre has received personal compensation for serving as an employee of UCB Inc. Dr. Dongre has stock in UCB Inc.
Antonio Gil-Nagel, MD	Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EISAI . Dr. Gil-Nagel has received personal compensation in the range of $0-$499 for serving as a Consultant for GW Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Angelini Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EISAI. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics . Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoke . Dr. Gil-Nagel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zogenix . Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Angelini Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BIAL . Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EISAI . Dr. Gil-Nagel has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for GW Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PTC Therapeutics . Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zogenix . The institution of Dr. Gil-Nagel has received research support from Jazz Pharmaceuticals. The institution of Dr. Gil-Nagel has received research support from PTC Therapeutics. The institution of Dr. Gil-Nagel has received research support from Zogenix. The institution of Dr. Gil-Nagel has received research support from Agencia Estatal Innovacion.
Scott T. Demarest, MD	The institution of Dr. Demarest has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. The institution of Dr. Demarest has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Capsida. The institution of Dr. Demarest has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. The institution of Dr. Demarest has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mahzi. The institution of Dr. Demarest has received personal compensation in the range of $500-$4,999 for serving as a Consultant for neurocrine. The institution of Dr. Demarest has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. The institution of Dr. Demarest has received research support from NIH. Dr. Demarest has a non-compensated relationship as a SMAB with SLC6A1 Connect that is relevant to �鶹��ýӳ�� interests or activities. Dr. Demarest has a non-compensated relationship as a SMAB with Ring 14 USA that is relevant to �鶹��ýӳ�� interests or activities. Dr. Demarest has a non-compensated relationship as a SMAB with FamilieSCN2A that is relevant to �鶹��ýӳ�� interests or activities.

�鶹��ýӳ��

�鶹��ýӳ��